BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35579782)

  • 1. Recurrent ipsilateral pheochromocytoma in carriers of RET p.Cys634 missense mutations.
    Machens A; Lorenz K; Weber F; Dralle H
    Endocrine; 2022 Jun; 77(1):160-167. PubMed ID: 35579782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamine crisis as a first manifestation of familial bilateral pheochromocytoma caused by RET proto-oncogene mutation in codon C 634R.
    Zwolak A; Rudzki G; Świrska J; Dudzińska M; Daniluk J; Tarach J
    Endokrynol Pol; 2015; 66(5):462-8. PubMed ID: 26457501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-oriented approach to hereditary adrenal pheochromocytoma.
    Machens A; Brauckhoff M; Gimm O; Dralle H
    Ann N Y Acad Sci; 2006 Aug; 1073():417-28. PubMed ID: 17102110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical patterns and RET proto-oncogene identification of pheochromocytoma in 13 multiple endocrine neoplasia type 2A pedigrees].
    Qi XP; Chen ZG; Jin HY; Li F; Cheng J; Ying RB; Zhao JQ; Guo DG; Luo SY; Chen GP; Zhang XN
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2200-4. PubMed ID: 24169328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pheochromocytoma as the first manifestation of MEN2A with RET mutation S891A: report of a case.
    Hibi Y; Ohye T; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Uchino S; Kosugi S; Kurahashi H; Iwase K
    Surg Today; 2014 Nov; 44(11):2195-200. PubMed ID: 24449023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of bilateral adrenal pheochromocytoma with RET gene mutation combined with medullary sponge kidney: A case report.
    Shen P; Yin N; Sun L; Liu Y; Cao X
    Medicine (Baltimore); 2023 Jun; 102(23):e34022. PubMed ID: 37335636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unilateral subtotal adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2 patients: a feasible surgical strategy.
    Scholten A; Valk GD; Ulfman D; Borel Rinkes IH; Vriens MR
    Ann Surg; 2011 Dec; 254(6):1022-7. PubMed ID: 22107743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene.
    Akama H; Noshiro T; Kimura N; Shimizu K; Watanabe T; Shibukawa S; Nakai S; Miura W; Ito S; Miura Y
    Intern Med; 1999 Feb; 38(2):145-9. PubMed ID: 10225670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A newly detected mutation of the RET protooncogene in exon 8 as a cause of multiple endocrine neoplasia type 2A.
    Bethanis S; Koutsodontis G; Palouka T; Avgoustis C; Yannoukakos D; Bei T; Papadopoulos S; Linos D; Tsagarakis S
    Hormones (Athens); 2007; 6(2):152-6. PubMed ID: 17704047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrine neoplasia 2A (MEN 2A) syndrome.
    Breza J; Breza J
    Bratisl Lek Listy; 2018; 119(2):120-125. PubMed ID: 29455549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A.
    Asari R; Scheuba C; Kaczirek K; Niederle B
    Arch Surg; 2006 Dec; 141(12):1199-205; discussion 1205. PubMed ID: 17178962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pheochromocytoma recurrence in hereditary disease: does a cortical-sparing technique increase recurrence rate?
    Shirali AS; Clemente-Gutierrez U; Huang BL; Lui MS; Chiang YJ; Jimenez C; Fisher SB; Graham PH; Lee JE; Grubbs EG; Perrier ND
    Surgery; 2023 Jan; 173(1):26-34. PubMed ID: 36229248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
    Martins AF; Martins JM; do Vale S; Dias T; Silveira C; da Silva IR; Carmo-Fonseca M
    Hormones (Athens); 2016 Jul; 15(3):435-440. PubMed ID: 27838608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sparing surgery for bilateral pheochromocytoma].
    Shimoyama T; Saito J; Ito Y; Soyama A; Ito H; Nishikawa T; Kakuta Y; Nagata M; Yamaguchi K; Iizuka T
    Nihon Naika Gakkai Zasshi; 2004 Nov; 93(11):2416-8. PubMed ID: 15624479
    [No Abstract]   [Full Text] [Related]  

  • 15. Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma.
    Lee JE; Curley SA; Gagel RF; Evans DB; Hickey RC
    Surgery; 1996 Dec; 120(6):1064-70; discussion 1070-1. PubMed ID: 8957496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by the D631Y RET Mutation.
    Ospina NS; Maraka S; Donegan D; Morris JC
    Thyroid; 2017 Oct; 27(10):1332-1334. PubMed ID: 28747092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of RET Screening on the Management of Multiple Endocrine Neoplasia Type 2A: 10 Years Experience and Follow-Up in Three Families.
    Wang YP; Li FP; Wang HH; Fang XD; Zhu ZS; Chen YL; Qi XP
    Endocr Metab Immune Disord Drug Targets; 2022; 22(3):339-347. PubMed ID: 34445950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral Pheochromocytomas in MEN2A Syndrome: A Two-Institution Experience.
    Lang BH; Yu HW; Lo CY; Lee KE; Garcia-Barcelo MM; Woo YC; Lee PC; Wong KP; Tam PK; Lam KS
    World J Surg; 2015 Oct; 39(10):2484-91. PubMed ID: 26071011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical management of hereditary pheochromocytoma.
    Yip L; Lee JE; Shapiro SE; Waguespack SG; Sherman SI; Hoff AO; Gagel RF; Arens JF; Evans DB
    J Am Coll Surg; 2004 Apr; 198(4):525-34; discussion 534-5. PubMed ID: 15051000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple endocrine neoplasia type 2.
    Gertner ME; Kebebew E
    Curr Treat Options Oncol; 2004 Aug; 5(4):315-25. PubMed ID: 15233908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.